CN Stock MarketDetailed Quotes

600200 JiangSu WuZhong Pharmaceutical Development

Watchlist
  • 10.08
  • -0.22-2.14%
Trading Dec 4 14:44 CST
7.18BMarket Cap-190188P/E (TTM)

JiangSu WuZhong Pharmaceutical Development Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
9.58%1.65B
9.62%1.21B
14.97%703.37M
10.55%2.24B
8.91%1.5B
40.01%1.1B
37.69%611.78M
14.12%2.03B
-5.96%1.38B
-24.02%786.09M
Operating revenue
9.58%1.65B
9.62%1.21B
14.97%703.37M
10.55%2.24B
8.91%1.5B
40.01%1.1B
37.69%611.78M
14.12%2.03B
-5.96%1.38B
-24.02%786.09M
Other operating revenue
----
-32.60%6.16M
----
13.47%15.76M
----
-1.53%9.14M
----
-5.17%13.89M
----
62.91%9.29M
Total operating cost
6.28%1.62B
8.89%1.19B
16.51%703.95M
10.17%2.34B
5.15%1.52B
34.00%1.1B
37.39%604.22M
13.11%2.13B
-6.27%1.45B
-23.71%818M
Operating cost
0.10%1.08B
7.75%854.82M
21.50%556.26M
17.27%1.7B
12.01%1.08B
54.06%793.36M
55.38%457.81M
14.49%1.45B
-10.42%961.75M
-33.45%514.96M
Operating tax surcharges
31.54%13.83M
28.08%9.25M
5.77%3.54M
-1.30%14.16M
2.38%10.51M
6.42%7.22M
-0.69%3.35M
19.33%14.34M
14.77%10.27M
15.10%6.78M
Operating expense
27.48%348.44M
8.84%209.96M
-4.67%85.06M
-10.02%403.37M
-12.96%273.32M
-0.32%192.91M
0.36%89.22M
8.15%448.31M
-2.89%314.03M
-5.31%193.54M
Administration expense
13.66%87.76M
12.49%59.02M
-1.08%27.1M
-0.12%116.48M
-10.33%77.21M
-2.79%52.47M
7.73%27.4M
11.16%116.61M
21.10%86.11M
24.18%53.97M
Financial expense
3.65%57.26M
21.03%40.02M
25.83%21.8M
1.44%72.4M
5.31%55.24M
0.14%33.07M
-10.26%17.33M
12.75%71.37M
8.72%52.46M
-0.05%33.02M
-Interest expense (Financial expense)
3.21%59.14M
18.96%41.62M
25.63%22.79M
2.34%76.34M
4.97%57.31M
0.34%34.99M
5.31%18.14M
15.35%74.6M
10.60%54.59M
3.02%34.87M
-Interest Income (Financial expense)
24.65%-2.58M
21.44%-1.79M
19.45%-939.44K
-2.10%-4.73M
-4.59%-3.42M
3.26%-2.28M
-351.06%-1.17M
-149.96%-4.64M
-120.50%-3.27M
-106.73%-2.36M
Research and development
12.59%31.29M
19.92%20.5M
11.88%10.19M
37.54%39.28M
24.98%27.79M
8.80%17.1M
11.93%9.11M
35.39%28.56M
21.89%22.24M
34.54%15.71M
Credit Impairment Loss
-34.20%-3.81M
-11.93%-1.52M
18.92%-1.07M
-237.21%-1.57M
-274.46%-2.84M
-34.86%-1.36M
-407.42%-1.32M
-77.30%1.15M
-46.30%1.63M
-124.03%-1.01M
Asset Impairment Loss
-151.73%-37.3K
68.41%-204.68K
51.22%-160.65K
4.30%-1.46M
-97.03%72.12K
-127.63%-647.83K
---329.36K
16.71%-1.53M
--2.42M
--2.34M
Other net revenue
-41.67%18.62M
-47.34%12.78M
-73.68%5.89M
22.52%29.89M
59.02%31.92M
95.38%24.27M
405.68%22.39M
-82.63%24.39M
-85.00%20.07M
-89.64%12.42M
Invest income
-83.72%4.93M
-78.81%4.71M
-105.20%-1.23M
141.19%29.17M
136.91%30.27M
175.14%22.23M
708.20%23.66M
-33.76%12.09M
-3.99%12.78M
-5.87%8.08M
-Including: Investment income associates
-120.44%-1.42M
-591.86%-1.64M
-469.64%-1.23M
----
68.70%6.95M
-86.26%332.63K
4,640.19%332.63K
----
-41.93%4.12M
-55.25%2.42M
Asset deal income
-108.50%-136.01K
-104.72%-86.43K
96.18%-5.8K
-668.59%-893.3K
1,205.18%1.6M
1,427.78%1.83M
-12.32%-151.79K
-99.84%157.11K
-100.14%-144.71K
-100.14%-138.03K
Other revenue
528.42%17.67M
347.38%9.88M
1,467.49%8.36M
-62.90%4.64M
-17.00%2.81M
-29.69%2.21M
-71.88%533.09K
-33.49%12.52M
-79.89%3.39M
-51.94%3.14M
Operating profit
253.23%49.01M
-10.62%25.72M
-82.26%5.32M
3.96%-72.16M
129.89%13.87M
247.70%28.78M
233.45%29.96M
-305.80%-75.14M
-180.04%-46.42M
-123.68%-19.48M
Add:Non operating Income
-67.45%60.2K
-88.11%14.07K
-91.30%9.02K
124.70%2.89M
-90.72%184.97K
-91.93%118.36K
-90.08%103.6K
-83.84%1.28M
-66.79%1.99M
-69.22%1.47M
Less:Non operating expense
-38.12%996.66K
-73.43%352.89K
-96.35%48.36K
23.67%1.92M
4.57%1.61M
-13.42%1.33M
152.67%1.33M
-70.24%1.55M
-34.78%1.54M
18.27%1.53M
Total profit
286.16%48.07M
-7.93%25.38M
-81.64%5.28M
5.59%-71.19M
127.08%12.45M
241.01%27.57M
202.36%28.74M
-292.14%-75.4M
-174.58%-45.96M
-122.80%-19.55M
Less:Income tax cost
-68.23%948.68K
-32.36%833.25K
-47.75%602.78K
12.02%3.26M
23.55%2.99M
33.06%1.23M
-53.61%1.15M
-84.34%2.91M
-82.38%2.42M
-94.63%925.76K
Add:Adjusted items effecting net profit
----
----
----
----
----
----
---0.01
----
----
----
Net profit
398.00%47.12M
-6.78%24.55M
-83.06%4.67M
4.93%-74.45M
119.56%9.46M
228.61%26.34M
293.07%27.58M
-479.42%-78.32M
-200.98%-48.38M
-129.89%-20.48M
Net profit from continuing operation
398.00%47.12M
-6.78%24.55M
-83.06%4.67M
4.93%-74.45M
119.56%9.46M
228.61%26.34M
293.07%27.58M
-479.42%-78.32M
-200.98%-48.38M
-129.89%-20.48M
Less:Minority Profit
237.00%2.04M
108.81%93.91K
32.36%-386.22K
-22.54%-2.51M
4.06%-1.49M
-0.14%-1.07M
4.83%-570.98K
1.32%-2.05M
-5.18%-1.55M
2.87%-1.06M
Net profit of parent company owners
311.54%45.08M
-10.75%24.45M
-82.03%5.06M
5.67%-71.95M
123.39%10.95M
241.15%27.4M
269.61%28.15M
-435.74%-76.27M
-194.81%-46.83M
-127.89%-19.41M
Earning per share
Basic earning per share
320.00%0.063
-10.53%0.034
-82.50%0.007
9.09%-0.1
122.73%0.015
240.74%0.038
300.00%0.04
-466.67%-0.11
-195.65%-0.066
-127.55%-0.027
Diluted earning per share
320.00%0.063
-10.53%0.034
-82.50%0.007
9.09%-0.1
122.73%0.015
240.74%0.038
300.00%0.04
-466.67%-0.11
-195.65%-0.066
-127.55%-0.027
Other composite income
-10.72%-622.99K
80.81%-72.76K
26.76%-164.34K
69.81%-414.2K
19.14%-562.66K
-3.48%-379.21K
-256.41%-224.38K
91.23%-1.37M
95.40%-695.81K
-256.04%-366.45K
Other composite income of parent company owners
-10.72%-622.99K
80.81%-72.76K
26.76%-164.34K
69.81%-414.2K
19.14%-562.66K
-3.48%-379.21K
-256.41%-224.38K
91.23%-1.37M
95.40%-695.81K
-256.04%-366.45K
Total composite income
422.48%46.5M
-5.70%24.48M
-83.52%4.51M
6.05%-74.87M
118.13%8.9M
224.53%25.96M
282.06%27.36M
-1,693.16%-79.69M
-249.76%-49.08M
-130.32%-20.84M
Total composite income of parent company owners
327.83%44.46M
-9.77%24.38M
-82.47%4.89M
6.80%-72.36M
121.87%10.39M
236.62%27.02M
259.88%27.93M
-1,197.05%-77.64M
-238.76%-47.52M
-128.32%-19.78M
Total composite income of minority owners
237.00%2.04M
108.81%93.91K
32.36%-386.22K
-22.54%-2.51M
4.06%-1.49M
-0.14%-1.07M
4.83%-570.98K
1.32%-2.05M
-5.18%-1.55M
2.87%-1.06M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
--
ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 9.58%1.65B9.62%1.21B14.97%703.37M10.55%2.24B8.91%1.5B40.01%1.1B37.69%611.78M14.12%2.03B-5.96%1.38B-24.02%786.09M
Operating revenue 9.58%1.65B9.62%1.21B14.97%703.37M10.55%2.24B8.91%1.5B40.01%1.1B37.69%611.78M14.12%2.03B-5.96%1.38B-24.02%786.09M
Other operating revenue -----32.60%6.16M----13.47%15.76M-----1.53%9.14M-----5.17%13.89M----62.91%9.29M
Total operating cost 6.28%1.62B8.89%1.19B16.51%703.95M10.17%2.34B5.15%1.52B34.00%1.1B37.39%604.22M13.11%2.13B-6.27%1.45B-23.71%818M
Operating cost 0.10%1.08B7.75%854.82M21.50%556.26M17.27%1.7B12.01%1.08B54.06%793.36M55.38%457.81M14.49%1.45B-10.42%961.75M-33.45%514.96M
Operating tax surcharges 31.54%13.83M28.08%9.25M5.77%3.54M-1.30%14.16M2.38%10.51M6.42%7.22M-0.69%3.35M19.33%14.34M14.77%10.27M15.10%6.78M
Operating expense 27.48%348.44M8.84%209.96M-4.67%85.06M-10.02%403.37M-12.96%273.32M-0.32%192.91M0.36%89.22M8.15%448.31M-2.89%314.03M-5.31%193.54M
Administration expense 13.66%87.76M12.49%59.02M-1.08%27.1M-0.12%116.48M-10.33%77.21M-2.79%52.47M7.73%27.4M11.16%116.61M21.10%86.11M24.18%53.97M
Financial expense 3.65%57.26M21.03%40.02M25.83%21.8M1.44%72.4M5.31%55.24M0.14%33.07M-10.26%17.33M12.75%71.37M8.72%52.46M-0.05%33.02M
-Interest expense (Financial expense) 3.21%59.14M18.96%41.62M25.63%22.79M2.34%76.34M4.97%57.31M0.34%34.99M5.31%18.14M15.35%74.6M10.60%54.59M3.02%34.87M
-Interest Income (Financial expense) 24.65%-2.58M21.44%-1.79M19.45%-939.44K-2.10%-4.73M-4.59%-3.42M3.26%-2.28M-351.06%-1.17M-149.96%-4.64M-120.50%-3.27M-106.73%-2.36M
Research and development 12.59%31.29M19.92%20.5M11.88%10.19M37.54%39.28M24.98%27.79M8.80%17.1M11.93%9.11M35.39%28.56M21.89%22.24M34.54%15.71M
Credit Impairment Loss -34.20%-3.81M-11.93%-1.52M18.92%-1.07M-237.21%-1.57M-274.46%-2.84M-34.86%-1.36M-407.42%-1.32M-77.30%1.15M-46.30%1.63M-124.03%-1.01M
Asset Impairment Loss -151.73%-37.3K68.41%-204.68K51.22%-160.65K4.30%-1.46M-97.03%72.12K-127.63%-647.83K---329.36K16.71%-1.53M--2.42M--2.34M
Other net revenue -41.67%18.62M-47.34%12.78M-73.68%5.89M22.52%29.89M59.02%31.92M95.38%24.27M405.68%22.39M-82.63%24.39M-85.00%20.07M-89.64%12.42M
Invest income -83.72%4.93M-78.81%4.71M-105.20%-1.23M141.19%29.17M136.91%30.27M175.14%22.23M708.20%23.66M-33.76%12.09M-3.99%12.78M-5.87%8.08M
-Including: Investment income associates -120.44%-1.42M-591.86%-1.64M-469.64%-1.23M----68.70%6.95M-86.26%332.63K4,640.19%332.63K-----41.93%4.12M-55.25%2.42M
Asset deal income -108.50%-136.01K-104.72%-86.43K96.18%-5.8K-668.59%-893.3K1,205.18%1.6M1,427.78%1.83M-12.32%-151.79K-99.84%157.11K-100.14%-144.71K-100.14%-138.03K
Other revenue 528.42%17.67M347.38%9.88M1,467.49%8.36M-62.90%4.64M-17.00%2.81M-29.69%2.21M-71.88%533.09K-33.49%12.52M-79.89%3.39M-51.94%3.14M
Operating profit 253.23%49.01M-10.62%25.72M-82.26%5.32M3.96%-72.16M129.89%13.87M247.70%28.78M233.45%29.96M-305.80%-75.14M-180.04%-46.42M-123.68%-19.48M
Add:Non operating Income -67.45%60.2K-88.11%14.07K-91.30%9.02K124.70%2.89M-90.72%184.97K-91.93%118.36K-90.08%103.6K-83.84%1.28M-66.79%1.99M-69.22%1.47M
Less:Non operating expense -38.12%996.66K-73.43%352.89K-96.35%48.36K23.67%1.92M4.57%1.61M-13.42%1.33M152.67%1.33M-70.24%1.55M-34.78%1.54M18.27%1.53M
Total profit 286.16%48.07M-7.93%25.38M-81.64%5.28M5.59%-71.19M127.08%12.45M241.01%27.57M202.36%28.74M-292.14%-75.4M-174.58%-45.96M-122.80%-19.55M
Less:Income tax cost -68.23%948.68K-32.36%833.25K-47.75%602.78K12.02%3.26M23.55%2.99M33.06%1.23M-53.61%1.15M-84.34%2.91M-82.38%2.42M-94.63%925.76K
Add:Adjusted items effecting net profit ---------------------------0.01------------
Net profit 398.00%47.12M-6.78%24.55M-83.06%4.67M4.93%-74.45M119.56%9.46M228.61%26.34M293.07%27.58M-479.42%-78.32M-200.98%-48.38M-129.89%-20.48M
Net profit from continuing operation 398.00%47.12M-6.78%24.55M-83.06%4.67M4.93%-74.45M119.56%9.46M228.61%26.34M293.07%27.58M-479.42%-78.32M-200.98%-48.38M-129.89%-20.48M
Less:Minority Profit 237.00%2.04M108.81%93.91K32.36%-386.22K-22.54%-2.51M4.06%-1.49M-0.14%-1.07M4.83%-570.98K1.32%-2.05M-5.18%-1.55M2.87%-1.06M
Net profit of parent company owners 311.54%45.08M-10.75%24.45M-82.03%5.06M5.67%-71.95M123.39%10.95M241.15%27.4M269.61%28.15M-435.74%-76.27M-194.81%-46.83M-127.89%-19.41M
Earning per share
Basic earning per share 320.00%0.063-10.53%0.034-82.50%0.0079.09%-0.1122.73%0.015240.74%0.038300.00%0.04-466.67%-0.11-195.65%-0.066-127.55%-0.027
Diluted earning per share 320.00%0.063-10.53%0.034-82.50%0.0079.09%-0.1122.73%0.015240.74%0.038300.00%0.04-466.67%-0.11-195.65%-0.066-127.55%-0.027
Other composite income -10.72%-622.99K80.81%-72.76K26.76%-164.34K69.81%-414.2K19.14%-562.66K-3.48%-379.21K-256.41%-224.38K91.23%-1.37M95.40%-695.81K-256.04%-366.45K
Other composite income of parent company owners -10.72%-622.99K80.81%-72.76K26.76%-164.34K69.81%-414.2K19.14%-562.66K-3.48%-379.21K-256.41%-224.38K91.23%-1.37M95.40%-695.81K-256.04%-366.45K
Total composite income 422.48%46.5M-5.70%24.48M-83.52%4.51M6.05%-74.87M118.13%8.9M224.53%25.96M282.06%27.36M-1,693.16%-79.69M-249.76%-49.08M-130.32%-20.84M
Total composite income of parent company owners 327.83%44.46M-9.77%24.38M-82.47%4.89M6.80%-72.36M121.87%10.39M236.62%27.02M259.88%27.93M-1,197.05%-77.64M-238.76%-47.52M-128.32%-19.78M
Total composite income of minority owners 237.00%2.04M108.81%93.91K32.36%-386.22K-22.54%-2.51M4.06%-1.49M-0.14%-1.07M4.83%-570.98K1.32%-2.05M-5.18%-1.55M2.87%-1.06M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership)------ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data